Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve 1. To consider, approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries has informed BSE that its Board of Directors will meet on Tuesday, 12 August 2025. The main item on the agenda is to consider and approve the unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26). Any other business may be taken up with the chair's permission. The trading window for designated persons has been closed since 1 July 2025 and will reopen 48 hours after the results are announced. This is a standard regulatory filing under SEBI's Listing Obligations and Disclosure Requirements.
This is a routine pre-results intimation with no fresh financial data for investors to act on. Shareholders should watch the actual Q1 results expected on 12 August 2025 to assess the company's quarterly performance.